Direct cytoplasmic delivery of RNAi therapeutics through a non-lysosomal pathway for enhanced gene therapy

RNA干扰 基因沉默 小干扰RNA 核糖核酸 基因敲除 细胞生物学 小发夹RNA 生物 遗传增强 内吞作用 细胞 基因 生物化学
作者
Jie Zhou,Junjie Zhang,Senyan Chen,Qinghua Lin,Rong Zhu,Liping Wang,Xiaole Chen,Jingying Li,Huanghao Yang
出处
期刊:Acta Biomaterialia [Elsevier BV]
卷期号:170: 401-414 被引量:8
标识
DOI:10.1016/j.actbio.2023.08.039
摘要

The first approved RNAi therapeutics, ONPATTRO, in 2017 moves the concept of RNA interference (RNAi) therapy from research to clinical reality, raising the hopes for the treatment of currently incurable diseases. However, RNAi therapeutics are still facing two main challenges-susceptibility to enzymatic degradation and low ability to escape from endo/lysosome into the cytoplasm. Therefore, we developed disulfide-based nanospheres (DBNPs) as universal vehicles to achieve efficient RNA delivery to address these problems. Notably, the DBNPs possess unique and desirable features, including improved resistance to nuclease degradation, direct cytoplasmic delivery through thiol-mediated cellular uptake, and cytosolic environment-responsive release, greatly enhancing the bioavailability of RNA therapeutics. Additionally, DBNPs are superior in terms of overcoming formidable physiological barriers, including vascular barriers and impermeable tumor tissues. Owning to these advantages, the DBNPs exhibit efficient gene silencing effect when delivering either small interfering RNA (siRNA) or microRNA in various cell lines and generate remarkable growth inhibition in the zebrafish and mouse model of pancreatic tumors as compared to traditional delivery vectors, such as PEI. Therefore, DBNPs have potential application prospect in RNAi therapy both in vitro and in vivo. STATEMENT OF SIGNIFICANCE: RNA interference (RNAi) therapeutics could target and alter any disease-related mRNA translation, thus have great potential in clinical application. Delivery efficiency of RNA modalities into cell cytoplasm is the main problem that currently limit RNAi therapeutics to release their full potential. Most of the known delivery materials suffer from the endo/lysosomal entrapment and enzymatic degradation during endocytosis-dependent uptake, resulting unsatisfied efficiency of the cytoplasmic release. Here, we developed disulfide-based nanospheres could directly transfer RNA modalities into the cytoplasm and significantly enhance the delivery efficiency, thus holding great potential in RNAi therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
调皮曼冬完成签到,获得积分10
刚刚
沉默听云发布了新的文献求助10
刚刚
When完成签到 ,获得积分10
1秒前
duanxy发布了新的文献求助10
1秒前
Ava的应助被芳非采纳,获得10
1秒前
吃不吃麻辣烫完成签到,获得积分10
1秒前
好运降林女士完成签到,获得积分10
1秒前
北辰小狼完成签到,获得积分10
1秒前
2秒前
gjh完成签到,获得积分10
2秒前
茯苓薏米茶完成签到,获得积分10
2秒前
锐锐子顺利毕业完成签到,获得积分10
2秒前
XXX完成签到,获得积分10
2秒前
酷酷的树叶完成签到,获得积分10
2秒前
3秒前
高兴的苞络完成签到,获得积分10
3秒前
keyanzhang发布了新的文献求助10
3秒前
Tsuki完成签到,获得积分10
3秒前
HHHH完成签到,获得积分10
3秒前
叶破茧完成签到,获得积分10
3秒前
告捷完成签到,获得积分10
4秒前
楠D完成签到,获得积分10
4秒前
757龙完成签到,获得积分10
4秒前
4秒前
cccc完成签到,获得积分10
4秒前
YellowStar完成签到,获得积分10
4秒前
111完成签到,获得积分10
4秒前
4秒前
张伟发布了新的文献求助10
5秒前
Xxx完成签到,获得积分10
5秒前
灰色的乌完成签到,获得积分10
5秒前
wyy完成签到 ,获得积分10
6秒前
qf完成签到,获得积分10
6秒前
6秒前
miruqi完成签到,获得积分10
6秒前
赤子心i完成签到 ,获得积分10
6秒前
yangdoudou完成签到,获得积分10
6秒前
在水一方的应助被吾吾采纳,获得10
6秒前
sir完成签到 ,获得积分10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180488
求助须知:如何正确求助?哪些是违规求助? 9570437
关于积分的说明 21812406
捐赠科研通 7776516
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557516
邀请新用户注册赠送积分活动 2479162